Delivery Order SPE2DB20D1109-SPE2DB25FP66H
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,809.76 to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packs (30-count) on August 15, 2025. This firm fixed-price delivery order, with performance completion targeted for August 18, 2025, is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $4,935.50 to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packs of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract does not include a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $4,959.12 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Alvimopan 12 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion date of August 8, 2025, and performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsule unit dose packages (30-count) on August 14, 2025, with a ceiling value of $26,853.88 and an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $11,346.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 unit-dose capsules of Alvimopan 12 mg, with a completion date of July 23, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The product is being delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsules in unit dose packaging (30-count), valued at $2,152.36 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alvimopan 12 mg capsules and has a ceiling value of $9,615.12. It is a firm-fixed-price delivery order with a period of performance through May 14, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,080.46 firm fixed-price delivery order is for the provision of 4,564,898,629 units of the prescription medication Alvimopan 12 mg capsules. The award does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,601,268 units of the pharmaceutical product Alvimopan 12 mg capsules. The total ceiling value of the contract is $47,144.31, with a performance period extending to June 23, 2025. The contract is not set aside and was awarded on an open competition basis....
- This is a $24,354.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALVIMOPAN 12 MG CAPSULE UD 30S, a medical product, and has an ultimate completion date of December 31, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP66HDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,807.56 to AmerisourceBergen Drug Corp for Alvimopan 12 mg capsules in unit dose packaging of 30 units. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its expansive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's delivery orders under the DLA Troop Support Medical IDC support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a diverse range of pharmaceutical products across multiple therapeutic domains. Alvimopan, a gastrointestinal agent typically used to accelerate postoperative bowel function recovery, represents one element of the company's extensive medical commodity support to the federal government. All of AmerisourceBergen Drug Corp's reviewed federal contract awards have been competitively awarded without set-asides, demonstrating the company's capability to meet federal procurement requirements in open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/29/25 |